Scinovex
articleTop 1% cited

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

Urology · 2002 · Vol. 60(3) · pp. 434–441
Claus G. RoehrbornPeter BoyleJ. Curtis NickelK J HoefnerGerald L. Andriole
Urinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentUrologic and reproductive health conditionsMedicineDutasterideUrologyPlaceboDihydrotestosteroneHyperplasiaProstate5 Alpha-Reductase InhibitorTransrectal ultrasonographyInternal medicine

MeSH terms

DutasterideAgedAzasteroidsDouble-Blind MethodDrug Administration ScheduleFollow-Up StudiesHumansMaleOtorhinolaryngologic DiseasesPlacebosProstateProstatic HyperplasiaDihydrotestosteroneTreatment OutcomeProstate-Specific Antigen
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.